AimTo evaluate the impact of sodium glucose cotransporter 2 inhibitors (SGLT-2i) on risk of heart failure hospitalization in patients with type 2 diabetes. MethodsWe searched the PubMed. Embase. The Cochrane Library. https://www.markymarkscott.com/product-category/p03/